Pathogenetic approaches to the treatment of chronic liver diseases with the presence of intrahepatic cholestasis


Дәйексөз келтіру

Толық мәтін

Аннотация

The article includes discussion of the problem of intrahepatic cholestatasis (IC), which can be the syndrome of acute and chronic liver diseases and separate disease with morphologic and biochemistry changes caused by disorders of bile outflow. The article describes the approaches to treatment using drugs affecting different stages of pathogenesis: geptral - bioactive compound and analog of natural in cellular ademetionine and ursodeoxycholic acid drugs (UAD). Geptral is a hepatoprotector with antidepressive activity and choleretic and cholekinetic action, detoxication, regeneration, antioxidant, antifibrotic and neuroprotective effects. UAD cause the decreasing of the concentration of hydrophobic bile acids in enterohepatic circulation, preventing its toxic effect on hepatocyte membranes and epithelium of biliary duct, and also have immunomodulating and anti-inflammatory effect.

Әдебиет тізімі

  1. Буеверов А.О. Лекарственные поражения печени как причина внутрипеченочного холестаза // Клинические перспективы гастроэнтерологии, гепатологии. 2005. № 6. С. 1-5.
  2. Яковенко Э.П., Григорьев П.Я., Агафонова Н.А. и др. Внутрипеченочный холестаз - от патогенеза к лечению // Практикующий врач. 1998. № 13 (2). С. 20-24.
  3. Bianchi G, Buganesi E, Ronchi M, et al. Glutation kinetics in normal man and in patients with liver cirrosis. J Hepatology 1997;26(3):606-13.
  4. Burgunder JM, Lauterburg BH. Decreased production of glutathione in patients with cirrhosis. Eur J Clin Invest 1987;17:408-14.
  5. Catalino F, Scarponi S, Cesa F, et al. Efficacy and safety of intravenous S-Adenosyl-L-Methionine therapy in the management of intrahepatic cholestasis of pregnancy. Drug Invest 1992;4(Suppl. 4):78-82.
  6. Chawla RK, Lewis FW, Kutner MH, et al. Plasma cysteine, cystine, and glutathione in cirrhosis. Gastroenterology 1984;87:770-76.
  7. De Caestecker JS, Jazrawi RP, et al. Ursodeoxycholic acid in chronic liver disease. Cut 1991;32:1061-65.
  8. Erlinger S. Do intracellular organelles have any role in transport of bile acids by the hepatocytes. J Hepatology 1996;24:88-93.
  9. Fallon MB, Anderson JM, Boyer JL. Intrahepatic cholestasis. In: Schiff L, Schiff E.R., eds. Diseases of the liver, 7th Ed. - Ed. - J.B.Lippincott comp., Philadelphia. 1993:343-61.
  10. Frezza M, Terpin M. The use of S- adenosyl - L - methionine in the treatment of cholestasis disorders. A meta - analysis of clinical trials. Drug Invest 1992;4(Suppl. 4):101-08.
  11. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;355:1570-80.
  12. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995;332:924-33.
  13. Manzillo G, Piccinino F, Surrenti C, et al. Multicentre double-blinde, placebo-controlled study of intravenous and oral S-Adenosyl-L-Methionine cholestasis patients with liver disease. Drug Invest 1992;4(Suppl. 4):90-100.
  14. Martinez-Chantar ML, Garsia-Trevi-jano ER, Latasa MU, et al. Importance of a deficiency in S-adenosyl-L-methionine syntesis in the pathogenesis of the liver injury. Am J Clin Nutr 2002;76:1177S-1182S.
  15. Nathanson MN, Boyer JL. Mechanisms and regulation of bile secretion. Hepatology 1991;14:551-54.
  16. Osman E, Owen JS, Burroughs AK. Review article : S-Adenosyl-L-Methionine- a new therapeutic agent in liver disease ? Aliment Pharmacol Ther 1993;7:21-28.
  17. Reichen J. Pharmacologic Treatment of cholestasis. In seminars in liver disease. Thieme Med. Publishers Inc. New York, 1993;13(3):302-15.
  18. Schaffner F. Cholestasis. In Millward-Sadler G.H. Wright R., Arthur M.J.P., eds. Liver and biliary disease. Pathophysiology, diagnosis and management. WB Saunders Co. Ltd. London 1992:371-96.
  19. Sherlock S, Dooley J. Diseasis of the liver and biliary system, 10 th ck. Blackwell Sci. Publications - Oxford 1997:217-38.
  20. Smith DJ, Gordon ER. Membrane fluidity and cholestasis. J Hepatology 1987;5:362-68.
  21. Song Z, Barve S, Chen T, et al. S-adenosylmethionine (AdoMet) modulates endotoxin stimulated interleukin-10 production in monocytes. Am J Physiol Gastro Intest Liver Physiol 2003;284:949-55.
  22. Stremmel W, Tiribelli C, Vyska K. Multiplicity of sinusoidal membrane carrier systems of organic anions. In Tavoloni N., Berk P.D., eds. Hepatic transport and bile secretion. Physiology and pathophysiology. New York Raven Press 1993:225-34.
  23. http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2292&mid=1085056570&magid=172&full=1

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>